Movano (NASDAQ:MOVE) Lowered to “Sell” Rating by Wall Street Zen

Movano (NASDAQ:MOVE) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Sunday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Movano in a report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Movano has a consensus rating of “Sell”.

Movano Price Performance

NASDAQ MOVE opened at $11.77 on Friday. Movano has a 1-year low of $4.67 and a 1-year high of $54.40. The firm has a market capitalization of $13.42 million, a P/E ratio of -1.09 and a beta of 0.81. The business’s 50-day simple moving average is $10.23 and its 200-day simple moving average is $8.51.

Movano (NASDAQ:MOVE) last posted its quarterly earnings results on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, beating the consensus estimate of ($7.00) by $2.27. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%. The firm had revenue of $0.08 million for the quarter, compared to analyst estimates of $3.88 million.

Insider Activity

In other Movano news, CEO John Mastrototaro sold 33,069 shares of Movano stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $20.80, for a total transaction of $687,835.20. Following the sale, the chief executive officer directly owned 56,114 shares in the company, valued at $1,167,171.20. The trade was a 37.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CTO Michael Aaron Leabman sold 6,845 shares of the stock in a transaction that occurred on Wednesday, January 14th. The shares were sold at an average price of $6.66, for a total value of $45,587.70. Following the transaction, the chief technology officer owned 22,639 shares of the company’s stock, valued at approximately $150,775.74. This trade represents a 23.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 94,383 shares of company stock worth $1,524,933 over the last ninety days. Corporate insiders own 10.40% of the company’s stock.

Institutional Trading of Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC bought a new position in Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned approximately 5.94% of Movano at the end of the most recent quarter. Institutional investors and hedge funds own 16.64% of the company’s stock.

Key Movano News

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Cooler inflation and stronger jobs data raised bets on future rate cuts, which can support speculative/small‑cap stocks like Movano if investors rotate back into risk assets; this macro tailwind may blunt some selling pressure. Article Title
• Positive Sentiment: Clinical progress in large pharma (e.g., Bristol‑Myers Squibb moving a stroke trial forward) can lift sentiment for healthcare and medtech names broadly; while not directly tied to Movano, positive clinical news can improve sector flows. Article Title
• Neutral Sentiment: Micron’s strong comments and stock strength highlight a bifurcation within tech — large cap semis can rally while smaller tech/health names lag; this divergence helps explain why MOVE can underperform even on otherwise positive tape. Article Title
• Neutral Sentiment: Company/industry governance and scheduling headlines (e.g., shareholder meeting notices from other small issuers) have limited direct impact on Movano but are part of a broader small‑cap news flow backdrop. Article Title
• Negative Sentiment: Broad tech weakness and fresh worries around AI disruption drove a sharper down‑move in U.S. stocks, pressuring small tech/health stocks with weak liquidity — a direct headwind for Movano’s thinly traded shares. Article Title
• Negative Sentiment: Geopolitical/regulatory actions hitting big tech (e.g., Russia blocking WhatsApp) increase market uncertainty and can amplify risk‑off flows that tend to hit small, speculative names harder. Article Title

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.